[go: up one dir, main page]

MX2010004262A - Formulaciones topicas de glicopirrolato. - Google Patents

Formulaciones topicas de glicopirrolato.

Info

Publication number
MX2010004262A
MX2010004262A MX2010004262A MX2010004262A MX2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A MX 2010004262 A MX2010004262 A MX 2010004262A
Authority
MX
Mexico
Prior art keywords
formulations
further comprise
glycopyrrolate formulations
topical glycopyrrolate
polymer
Prior art date
Application number
MX2010004262A
Other languages
English (en)
Inventor
Michael Johnston
Robert James Houlden
Original Assignee
Stiefel Res Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567708&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010004262(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Res Australia Pty Ltd filed Critical Stiefel Res Australia Pty Ltd
Publication of MX2010004262A publication Critical patent/MX2010004262A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formulaciones tópicas empacadas de manera individual que comprenden de aproximadamente 0.25 a aproximadamente 6% en peso/peso de glicopirrolato para el tratamiento de la hiperhidrosis, en donde la toallita está contenida dentro de una bolsita resistente a las fugas; las formulaciones pueden comprender además etanol, un agente amortiguador y agua, además, las formulaciones pueden comprender un sistema polimérico que comprende un polímero hidrofóbico en combinación con un polímero hidrofílico.
MX2010004262A 2007-10-18 2008-10-17 Formulaciones topicas de glicopirrolato. MX2010004262A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96088707P 2007-10-18 2007-10-18
PCT/US2008/011907 WO2009051818A1 (en) 2007-10-18 2008-10-17 Topical glycopyrrolate formulations

Publications (1)

Publication Number Publication Date
MX2010004262A true MX2010004262A (es) 2010-05-14

Family

ID=40567708

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004262A MX2010004262A (es) 2007-10-18 2008-10-17 Formulaciones topicas de glicopirrolato.

Country Status (7)

Country Link
US (7) US8618160B2 (es)
EP (2) EP3415127B1 (es)
AU (2) AU2008314628B2 (es)
CA (1) CA2702830C (es)
ES (2) ES2671874T3 (es)
MX (1) MX2010004262A (es)
WO (1) WO2009051818A1 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010511723A (ja) * 2006-12-04 2010-04-15 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 局所医薬組成物
CA2702830C (en) 2007-10-18 2017-02-28 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations
WO2011076840A2 (en) * 2009-12-23 2011-06-30 Chiesi Farmaceutici S.P.A. Aerosol formulation for copd
ES2468840T7 (es) 2009-12-23 2023-11-29 Chiesi Farm Spa Terapia combinada para EPOC
NZ600789A (en) 2009-12-23 2014-09-26 Chiesi Farma Spa Aerosol formulation for copd
JP6242402B2 (ja) 2013-01-03 2017-12-06 ハイドロス セラピューティクス インターナショナル アクチエボラグ 多汗症の治療
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
KR102232806B1 (ko) 2013-02-28 2021-03-29 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US20220233500A1 (en) * 2014-08-29 2022-07-28 Journey Medical Corporation Glycopyrrolate salts
WO2014144075A1 (en) 2013-03-15 2014-09-18 Bodor Laboratories, Inc. Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis
PE20160198A1 (es) * 2013-07-30 2016-04-21 Glaxosmithkline Ip Dev Ltd Composiciones topicas para el tratamiento de sudoracion excesiva y metodos para utilizar las mismas
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US9926270B2 (en) 2014-08-20 2018-03-27 Dermira, Inc. Process for production of glycopyrronium tosylate
US20160058735A1 (en) * 2014-08-27 2016-03-03 Dermira, Inc. Methods of treating hyperhidrosis
WO2016062584A1 (en) 2014-10-24 2016-04-28 Unilever Plc Dispenser for a cream, gel or soft solid composition
WO2016062586A1 (en) 2014-10-24 2016-04-28 Unilever Plc Method of controlling perspiration
US10227594B2 (en) 2015-03-20 2019-03-12 Conopco, Inc. Antiperspirant composition
CN108137612A (zh) 2015-07-21 2018-06-08 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
PT109445B (pt) 2016-06-08 2018-11-06 Hovione Farm Sa Co-cristais farmacêuticos cristalinos de brometo de glicopirrónio com lactose
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
CA3030772A1 (en) 2016-08-02 2018-02-08 Dermira, Inc. Processes for making, and methods of using, glycopyrronium compounds
EP3860589A4 (en) 2018-11-06 2022-06-08 Harman Finochem Limited METHOD FOR PREPARING GLYCOPYRROLATE TOSYLATE
BR112022004141A2 (pt) 2019-09-20 2022-05-31 Unilever Ip Holdings B V Uso não terapêutico
WO2021113260A1 (en) 2019-12-02 2021-06-10 Dermira, Inc. Diester containing compounds for treating hyperhidrosis
BR112023023388A2 (pt) 2021-06-07 2024-01-23 Unilever Ip Holdings B V Composição antitranspirante e método cosmético de redução de transpiração

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2118566A (en) 1935-08-29 1938-05-24 Miles Gilbert De Wayne Buffered cosmetic
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
US3767786A (en) 1961-04-20 1973-10-23 Procter & Gamble Inhibiting perspiration with scopolamine esters
IL22666A (en) 1964-01-06 1968-10-24 Robins Co Inc A H Compositions for inhibiting perspiration containing an 1,1-dialkyl-3-hydroxy-pyrrolidinium ester of an alpha-phenyl-alpha-cycloalkyl-clycolic or acetic acid
US3312709A (en) 1964-06-29 1967-04-04 Procter & Gamble Para-(lower)alkoxybenzoylscopolamine
DE1670048C3 (de) 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate
US4355020A (en) * 1977-11-12 1982-10-19 Bert Kuy Thixotropic aluminum hydroxide chloride and medical and other applications thereof
CA1120874A (en) * 1978-04-14 1982-03-30 Ralph G. Amberg Composite container
US4415551A (en) * 1982-01-29 1983-11-15 The Gillette Company Bioerodible deodorant
US4824676A (en) 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4891227A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
GB8811408D0 (en) * 1988-05-13 1988-06-15 Unilever Plc Cosmetic composition
US4883792A (en) * 1989-01-17 1989-11-28 Peter Timmins Steroid cream formulation
WO1993025186A1 (en) * 1992-06-16 1993-12-23 Klein Marvin E Composition for the treatment of skin
US5403588A (en) * 1993-11-23 1995-04-04 Santa Ana, Jr.; Cesareo T. Disposable body deodorant pad and deodorant preparation therefor
US5525347A (en) 1995-01-31 1996-06-11 Medical University Of South Carolina Composition and methods for treating performance anxiety
US5648083A (en) * 1995-02-10 1997-07-15 The Procter & Gamble Company Personal care compositions and wipe products containing the compositions
US5919760A (en) 1996-04-12 1999-07-06 Intensive Narcotic Detoxification Centers Of America, Llc Method for treating acute and severe diarrhea
US6214792B1 (en) 1996-04-12 2001-04-10 David Lew Simon Method for treating acute and severe diarrhea
WO1998000133A1 (en) 1996-07-01 1998-01-08 Sepracor, Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (s,s)-glycopyrrolate
US6204285B1 (en) 1996-07-01 2001-03-20 Sepracor Inc. Methods and compositions for treating urinary incontinence using enantiomerically enriched (R,R)-glycopyrrolate
AUPO379596A0 (en) * 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
ES2118053B1 (es) 1997-02-27 1999-03-01 Julia Capmany Font M Luisa Producto para la limpieza de la piel y faneras.
US5962505A (en) 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US5976499A (en) 1998-09-04 1999-11-02 Johns Hopkins University Macroscopic sweat test for cystic fibrosis
US6433003B1 (en) * 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6446795B1 (en) 2000-07-31 2002-09-10 The Gillette Company Towelette packaging
DE60119141T2 (de) * 2001-12-22 2007-02-01 The Procter & Gamble Company, Cincinnati Verpackung für zusammenpressbare Produkte sowie Verfahren zur Herstellung der Verpackung
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
CA2384922C (en) 2002-05-03 2008-09-02 Purepharm Inc. Topical glycopyrrolate product for the reduction of sweating
WO2006069998A2 (de) * 2004-12-27 2006-07-06 Beiersdorf Ag Glycopyrrolat in kosmetischen zubereitungen
JP4991693B2 (ja) 2005-03-16 2012-08-01 メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 呼吸器疾患の治療のための抗コリン作用薬及びロイコトリエン受容体アンタゴニストの組み合わせ剤
CA2702830C (en) 2007-10-18 2017-02-28 Stiefel Research Australia Pty Ltd Topical glycopyrrolate formulations
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
KR102232806B1 (ko) 2013-02-28 2021-03-29 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate

Also Published As

Publication number Publication date
WO2009051818A1 (en) 2009-04-23
US8618160B2 (en) 2013-12-31
AU2014203072B2 (en) 2016-05-26
CA2702830C (en) 2017-02-28
AU2008314628B2 (en) 2014-03-06
AU2014203072A1 (en) 2014-07-03
US20100276329A1 (en) 2010-11-04
ES2671874T3 (es) 2018-06-11
US9744105B2 (en) 2017-08-29
EP2200550A4 (en) 2016-01-27
US11071694B2 (en) 2021-07-27
EP3415127B1 (en) 2023-12-20
US20140151255A1 (en) 2014-06-05
US20180311116A1 (en) 2018-11-01
US20250025379A1 (en) 2025-01-23
US10052267B2 (en) 2018-08-21
US20210290496A1 (en) 2021-09-23
EP2200550A1 (en) 2010-06-30
CA2702830A1 (en) 2009-04-23
EP3415127A1 (en) 2018-12-19
EP2200550B1 (en) 2018-04-18
ES2969237T3 (es) 2024-05-17
US20230270631A1 (en) 2023-08-31
US20180008517A1 (en) 2018-01-11
AU2008314628A1 (en) 2009-04-23
AU2014203072C1 (en) 2019-04-04

Similar Documents

Publication Publication Date Title
MX2010004262A (es) Formulaciones topicas de glicopirrolato.
MX2010009839A (es) Composiciones de saneamiento de la piel antimicrobianas de alcohol incluyendo espesadores compatibles cationicos.
WO2009074735A8 (fr) Utilisation d'un nouvel agent naturel dans des compositions cosmetiques
CA2713555C (en) Topical compositions and methods for whitening skin
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
WO2009090558A3 (en) Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
WO2007128939A3 (fr) Association d'un agent ou dispositif tenseur et d'un compose saccharidique
EP2070509A3 (en) The use of Myrica gale oil
WO2011053792A3 (en) Methods and compositions for sustained delivery of drugs
ES2356883A1 (es) Composicion para el tratamiento del dolor y/o la inflamacion.
MX2010006933A (es) Composiciones y metodos para reducir o prevenir la deshidratación de la piel.
WO2006013441A3 (en) Use of probiotic bacteria for the preparation of topical compositions for skin protection
AU2007211617A1 (en) Hydrogel
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
WO2008031940A3 (fr) Composition a base de xanthoxyline et son utilisation en cosmetique.
MX348531B (es) Dispositivo de lata de aerosol para suministro tópico dual.
WO2008069910A3 (en) Dual composition with warming and moisturising effects
AR066814A1 (es) Nuevo humectante y su utilizacion
GB0811053D0 (en) Compositions for the treatment of hair loss
CL2008002758A1 (es) Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento.
WO2007124382A3 (en) Inhaled imipenem
GB0606015D0 (en) therapeutic agents
AU321830S (en) Bottle
WO2009106555A3 (fr) Gel de sucralfate sterilise

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: ROSE U LLC

FG Grant or registration